Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle Cells
Open Access
- 1 July 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (29), 22435-22441
- https://doi.org/10.1074/jbc.m910452199
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Insulin signaling in the arterial wallThe American Journal of Cardiology, 1999
- Insulin Potentiates Platelet-Derived Growth Factor Action in Vascular Smooth Muscle Cells*This work was supported by grants from the VA Research Service, the NIH (HL-48920 to R.N., HD-24497–06 to J.S.), PO-1-HL-55798 (to J.N. and R.N.), jointly funded by the NIH and the Juvenile Diabetes Foundation, the American Heart Association, a fellowship support from the American Heart Association (to M.G.), HealthONE Foundation: Diabetes and Endocrine Research and Education Fund, and Foundation for Biomedical Education and Research.Endocrinology, 1998
- Role of the Rb/E2F pathway in cell growth controlJournal of Cellular Physiology, 1997
- Cancer Cell CyclesScience, 1996
- E2F and Cell Proliferation: A World Turned Upside DownCell, 1996
- Cell Biology of AtherosclerosisAnnual Review of Physiology, 1995
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGFScience, 1991
- Kinetics of vein graft hyperplasia: Association with tangential stressJournal of Vascular Surgery, 1987